PLP2
Proteolipid protein 2
Also known as: A4, A4-LSB, MGC126187, PLP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q04941
- Gene
- PLP2
- Ensembl
- ENSG00000102007
- Chromosome
- X
- Canonical length
- 152 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes an integral membrane protein that localizes to the endoplasmic reticulum in colonic epithelial cells. The encoded protein can multimerize and may function as an ion channel. A polymorphism in the promoter of this gene may be linked to an increased risk of X-linked cognitive disability. A pseudogene of this gene is found on chromosome 5. [provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
152 residues, UniProt reviewed canonical sequence.
>Q04941|PLP2
1 MADSERLSAP GCWAACTNFS RTRKGILLFA EIILCLVILI CFSASTPGYS SLSVIEMILA
61 AIFFVVYMCD LHTKIPFINW PWSDFFRTLI AAILYLITSI VVLVERGNHS KIVAGVLGLI
121 ATCLFGYDAY VTFPVRQPRH TAAPTDPADG PVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 369 nTPM
Expression across tissuesHPA
Tissue
- skin: 369 nTPM
- esophagus: 365 nTPM
- bone marrow: 339 nTPM
- blood vessel: 301 nTPM
- vagina: 257 nTPM
- pancreas: 246 nTPM
Single-cell type
- esophageal suprabasal cells: 1,311 nCPM
- esophageal basal cells: 1,131 nCPM
- esophageal apical cells: 1,071 nCPM
- suprabasal keratinocytes: 504 nCPM
- basal keratinocytes: 438 nCPM
- pdcs: 398 nCPM
Immune cell
- plasmacytoid DC: 696 nTPM
- basophil: 489 nTPM
- neutrophil: 321 nTPM
- myeloid DC: 299 nTPM
- classical monocyte: 288 nTPM
- T-reg: 267 nTPM
Brain region
- choroid plexus: 28 nTPM
- hypothalamus: 24 nTPM
- medulla oblongata: 20 nTPM
- thalamus: 19 nTPM
- midbrain: 18 nTPM
- spinal cord: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.55
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLP2 as an antibody target. Whether an autoantibody or antibody against PLP2 could matter depends on whether native PLP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLP2 is annotated at the cell surface, where native PLP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...